Full edition
$79.00
Free edition
Free
First name and email are collected at checkout for your receipt and download. No newsletter signup is included.
About this report
Hospital logistics automation should be assessed as a complete accepted delivery service, not a robot arriving near a ward. This report helps institutions define authorized payloads, routes, service windows, receiving responsibilities and fallback arrangements before discussing fleet size. It distinguishes Moxi, TUG and Relay architectures and their dated evidence while keeping movement separate from dispensing, specimen qualification, sterile processing, dietary decisions and patient care.
The guide pairs buyer analysis with working decision tools for general supplies, pharmacy packages, specimens, sterile supplies, meals, linen and waste. It follows the whole service through doors and elevators, accessibility, cleaning, dispatch, privacy, support access, workforce effects, reliability, capacity and contracting. Six companion CSVs provide structured decision and procurement records, a non-identifying observation log, dated sources and fictional scenarios that expose the difference between released staff capacity, cash savings and autonomous task completion.
Included in the customer ZIP
- 56-page full PDF report: HRR24_Hospital_Logistics_Robotics.pdf.
- 7-page free-preview PDF: HRR24_Free_Preview.pdf.
- decision_worksheets.csv: 150 editable fields across 25 institutional decision tools, with evidence, owner and review-status columns.
- RFP_and_acceptance.csv: the same 150 tool requirements arranged for supplier responses, hospital review and acceptance tracking; not 150 additional unique methods.
- job_observation_log.csv: non-identifying job template for lane, payload, timestamps, outcomes, failures and human-assistance time.
- economics_scenarios.csv: five static fictional USD scenarios separating net capacity, capacity value, cash benefit, recurring costs and one-time cost.
- sources.csv: eleven primary-source records with dates, URLs and bounded claims.
- worked_decision_case.csv: static fictional robot-versus-whole-service completion exercise from full-report page 43.
- READ_ME.txt with exact package inventory and companion-use guidance.
- METHODOLOGY_AND_REVIEW_STATUS.txt with dated methodology, production checks and publisher interests.
- THIRD_PARTY_NOTICES.txt with applicable third-party notices.
The paid download is HRR24_Customer_Download.zip, containing all 11 listed files: the full report, matching preview, six CSV data/reference files and three TXT guides/notices. CSVs are editable records or static examples, not automatically recalculating models. No XLSX workbook is included. Blank worksheets are not completed approvals; fictional exercises must remain separate from operational records.
The 7-page free preview includes the accepted-logistics buying position, evidence limitations and disclosure, sterile-supply boundaries, fictional capacity-versus-cash economics, the final investment framework and publisher methodology. The paid companion CSVs are not included.
Executive summary
Begin with a narrow, non-urgent lane, a named departmental owner and an available alternative service. Specialist mobile systems provide the strongest evidence within the reviewed sources; neither hospital adoption nor a humanoid appearance establishes clinical efficacy or permission to replace clinical judgment. Provider deployments, manufacturer milestones and live product offerings answer different questions. The report uses the UCSF specimen-transport example to show how a local route can exclude time-sensitive material without turning that institutional restriction into a universal product verdict.
Acceptance should follow the correct authorized item through accountable receipt, with loading, queues, cleaning, receiver delay, failed jobs and human intervention retained in the record. Pharmacy, laboratory, infection-prevention, facilities, accessibility, privacy and security gates remain institutional decisions. The financial case distinguishes capacity value from demonstrably avoided costs, and the fictional base deliberately remains cash-negative despite releasing staff time. Reversible pilots and contracts tied to the complete service make proceed, revise, defer or stop defensible outcomes; expanding to another payload or building requires fresh evidence.
Who this report is for
Hospital logistics, supply-chain and facilities teams defining eligible delivery lanes.
Pharmacy, laboratory, sterile-processing, food-service and infection-prevention reviewers assessing transport boundaries.
IT, privacy, accessibility and procurement teams evaluating the complete service and its dependencies.
Operations, finance and investment committees comparing workforce capacity, accepted service and financial exposure.
Coverage
Payload-specific scope
general replenishment, pharmacy-released packages, routine specimens, sterile supplies, meals, linen and waste, each with separate qualification and handoff ownership.
Specialist evidence
dated Moxi provider accounts and manufacturer claims, TUG and Relay offerings, model-specific references and limits on general-purpose humanoid conclusions.
Operating requirements
doors/elevators, accessible routes and interfaces, cleaning readiness, dispatch states, receiver acceptance, privacy/data flows, support access and continuity.
Procurement evidence
complete-work studies, reliability distributions, failure taxonomy, bounded pilots, fictional capacity/cash scenarios, return journeys, service contracts and board-ready decisions.
Key questions
- Which non-urgent payload and route can be qualified as a bounded service with an accountable recipient?
- What do provider deployments, manufacturer delivery milestones and current product descriptions actually establish?
- Where do clinical, infection-prevention, accessibility, privacy and security approvals limit the proposed scope?
- How much staff work remains in loading, receiving, cleaning and recovery, and which released hours are genuinely cashable?
- Which job-level evidence, fallback and contractual responsibilities would justify proceeding, narrowing or stopping?
Table of contents
Investment brief, evidence limitations, claims ledger, architecture and lane census
Page 5-10Moxi, TUG and Relay evidence, reference interviews and normalized quotations
Page 11-14General supplies, pharmacy transport, accountable receipt, specimens and sterile-supply boundaries
Page 15-23Meals, linen and waste, cart flow, building interfaces, accessibility and cleaning duties
Page 24-33Dispatch events, privacy/data-flow review, cybersecurity and support responsibilities
Page 34-39Workforce effects, complete-work observation, reliability, failure taxonomy and reversible pilots
Page 40-45Fictional capacity-versus-cash economics, full-cycle capacity and service contracts
Page 46-51Novel-platform evidence, investment decision, board-ready packet and publisher methodology
Page 52-56
Methodology
Public-source research retains an evidence cutoff of 16 October 2026 and review on 17 October 2026 UTC. The eleven-entry sources.csv records provider accounts, manufacturer announcements and product pages, UCSF local specimen guidance, and CDC/HHS guidance. Publication dates, historical deployment accounts and undated live material are distinguished; mutable pages do not prove availability at the historical cutoff.
Evidence is interpreted at the level it supports: a provider-reported deployment, vendor-reported cumulative activity, a product offering or an institutional requirement. These do not establish independently audited performance, transferable economics, clinical efficacy or current regional availability. The report contains no independent audit of a deployed fleet and makes bounded conclusions about the sources reviewed rather than all research demonstrations.
The 25 working tools and their CSV records are procurement frameworks requiring local professional review, not clinical procedures or completed approvals. Observation records are designed without patient identifiers. Five economics scenarios and the service-completion exercise are explicitly fictional; the tables are static and do not automatically recalculate. Capacity, cash benefit, robot completion and whole-service completion use distinct definitions.
Generative AI assisted research synthesis, drafting, analysis, calculations and graphics. Source comparisons, computational cross-checks, text/navigation checks and visual layout reviews were internal production checks, not external professional review, certification or an independent audit. No hands-on robot field tests or interviews were conducted.
Disclosures
This is research and institutional buyer analysis, not certification, clinical guidance, medical or legal advice. It does not authorize medication selection, dispensing, administration, specimen use, sterile processing, patient monitoring or care. Licensed professionals and the institution must qualify the exact payload, route, receiving workflow and relevant controls.
One Robotics Supply Group LLC publishes this report under Humanoid Robotics Reports. Its owner has ownership interests in related businesses, including robotics supply and distribution. As of 17 October 2026, the owner reports no investments in other companies covered by the collection and no current coverage-related sponsorship, dealer or referral connections. These are owner-reported statements, not independently audited; related-business ownership creates commercial interests readers should consider.
Named systems and institutions provide attributed, dated context, not endorsement, supplier certification, impartial-selection assurance or evidence that every site can reproduce a result. Current prices, exact contractual availability, regional support and site suitability require direct verification. Institutional guidance must not be generalized beyond its stated setting.
Fictional logistics and economic examples are not clinical outcomes, quotations, forecasts or acceptance thresholds. No infection reduction, patient benefit, return or autonomous-care capability is guaranteed. Later production checks do not refresh every underlying fact; future material coverage-related relationships or compensation require specific current disclosure.
Related reports
Senior Living Operations Robotics
A resident-centered buyer guide to dining, housekeeping and other nonclinical robotics support, with choice, accessibility, privacy and workforce frameworks plus six CSV companions.
Warehousing and Distribution Robotics
A distribution-center buyer guide to flow, fleet selection, system handoffs and measurable acceptance, with cost scenarios and a dated comparison of warehouse and humanoid deployment evidence.
Humanoid Robot Security, Privacy and Deployment Governance
A 54-page enterprise-buyer framework for robot data, remote access, software changes and deployment accountability. Separate privacy, cybersecurity and physical safety reviews, then connect the proposed operating scope to evidence, named owners and incident readiness.
Custom Research for Your Company
Need research tailored to your company’s suppliers, technologies, markets or business questions? Custom research is scoped and priced separately from this report.